[1]马洪俊,王玉平,刘 毅.主动脉内球囊反搏联合介入治疗急性心肌梗死伴心力衰竭的效果[J].医学信息,2022,35(13):136-138.[doi:10.3969/j.issn.1006-1959.2022.13.032]
　MA Hong-jun,WANG Yu-ping,LIU Yi.Effect of Intra-aortic Balloon Counterpulsation Combined with Interventional Therapy on Acute Myocardial Infarction Complicated with Heart Failure[J].Medical Information,2022,35(13):136-138.[doi:10.3969/j.issn.1006-1959.2022.13.032]
点击复制

主动脉内球囊反搏联合介入治疗急性心肌梗死伴心力衰竭的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年13期
页码:
136-138
栏目:
论著
出版日期:
2022-07-01

文章信息/Info

Title:
Effect of Intra-aortic Balloon Counterpulsation Combined with Interventional Therapy on Acute Myocardial Infarction Complicated with Heart Failure
文章编号:
1006-1959（2022）13-0136-03
作者:
马洪俊; 王玉平; 刘 毅
（天津市滨海新区海滨人民医院心脏内科，天津 300280）
Author(s):
MA Hong-jun; WANG Yu-ping; LIU Yi
(Department of Cardiology,Binhai People’s Hospital,Tianjin Binhai New Area,Tianjin 300280,China)
关键词:
主动脉内球囊反搏; 介入治疗; 急性心肌梗死; 心力衰竭
Keywords:
Intra-aortic balloon counterpulsation; Interventional therapy; Acute myocardial infarction; Heart failure
分类号:
R542.2+2
DOI:
10.3969/j.issn.1006-1959.2022.13.032
文献标志码:
A
摘要:
目的 观察主动脉内球囊反搏联合介入治疗急性心肌梗死伴心力衰竭的效果。方法 选取2018年4月-2021年4月在我院诊治的72例急性心肌梗死伴心力衰竭患者为研究对象，采用随机数字表法分为对照组和观察组，各36例。两组均给予介入治疗，观察组在介入治疗基础上联合应用主动脉内球囊反搏，比较两组治疗疗效、心功能指标、心功能分级情况以及不良反应发生情况。结果 观察组治疗总有效率为94.44%，高于对照组的83.33%，差异有统计学意义（P＜0.05）；两组N末端B型利尿钠肽原（NT-proBNP）均低于治疗前，左室舒张末期内径（LVEDd）及左室射血分数（LVEF）均高于治疗前，且观察组NT-proBNP低于对照组，LVEDd、LVEF均高于对照组，差异有统计学意义（P＜0.05）；观察组Ⅰ级心功能分级比例大于对照组，Ⅱ级、Ⅲ级、Ⅳ心功能分级比例均小于对照组，差异有统计学意义（P＜0.05）；观察组不良反应发生率为5.56%，与对照组的8.33%比较，差异无统计学意义（P＞0.05）。结论 主动脉内球囊反搏联合介入治疗急性心肌梗死伴心力衰竭效果确切，可提高治疗总有效率，改善心功能指标，促进心功能恢复，且不会增加不良反应，进一步提示该联合治疗方法有效、安全，值得临床应用。
Abstract:
Objective To observe the effect of intra-aortic balloon counterpulsation combined with interventional therapy on acute myocardial infarction with heart failure.Methods A total of 72 patients with acute myocardial infarction complicated with heart failure who were treated in our hospital from April 2018 to April 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 36 cases in each group. Both groups were treated with interventional therapy, and the observation group was treated with intra-aortic balloon counterpulsation on the basis of interventional therapy. The therapeutic efficacy, cardiac function index, cardiac function classification and adverse reactions of the two groups were compared.Results The total effective rate of the observation group was 94.44%, which was higher than 83.33% of the control group, and the difference was statistically significant (P<0.05). The N-terminal B-type natriuretic peptide (NT-proBNP) in the two groups was lower than that in the treatment, and the left ventricular end-diastolic diameter (LVEDd) and left ventricular ejection fraction (LVEF) were higher than those before treatment, and the NT-proBNP in the observation group was lower than that in the control group, and LVEDd and LVEF were higher than those in the control group, with statistically significant difference (P<0.05). The proportion of cardiac function grade Ⅰ in the observation group was higher than that in the control group, and the proportion of cardiac function grades Ⅱ, Ⅲ and Ⅳ in the observation group was lower than that in the control group, the difference was statistically significant (P<0.05). The incidence of adverse reactions in the observation group was 5.56%, which was compared with 8.33% in the control group, the difference was not statistically significant(P>0.05).Conclusion Intra-aortic balloon counterpulsation combined with interventional therapy is effective in the treatment of acute myocardial infarction complicated with heart failure, which can improve the total effective rate, improve cardiac function indexes, promote the recovery of cardiac function, and do not increase adverse reactions. It further suggests that the combined treatment is effective and safe, and is worthy of clinical application.

参考文献/References:

[1]许晶晶,高展,宋莹,等.主动脉内球囊反搏在经皮冠状动脉介入治疗中的应用[J].中华心血管病杂志,2017,45(7):572-578.[2]陈国藩,王丽.急性心肌梗死伴心力衰竭患者主动脉内球囊反搏辅助介入治疗效果评价[J].中华全科医学,2017,15(6):23-26.[3]王瑞钰,罗素新.PCI术前应用IABP辅助治疗对于急性心肌梗死患者临床疗效的系统评价[J].大连医科大学学报,2016,38(3):88-90.[4]张艳,赵昕,韩雅玲,等.比伐卢定对IABP辅助下急性心肌梗死行PCI患者的疗效及血小板数量的影响[J].中华老年多器官疾病杂志,2016,15(2):152-154.[5]李根,李馨妍,王耿.主动脉内球囊反搏术对接受急诊经皮冠状动脉介入术急性ST段抬高型心肌梗死合并心源性休克患者影响研究[J].临床军医杂志,2020,48(5):566-568.[6]申明伟,崔雪林,白杨,等.主动脉内球囊反搏术在高危冠心病患者介入治疗中的应用[J].兵团医学,2017,51(1):15-16.[7]杜娜.超敏肌钙蛋白T与肌钙蛋白I诊断急性心肌梗死的临床价值[J].中西医结合心血管病电子杂志,2018,6(24):72.[8]傅庆华,郑昭芬.IABP辅助治疗对急性ST段抬高型心肌梗死合并重度心衰患者预后的影响[J].医学临床研究,2016,33(4):758-760.[9]李明臣.增强型体外反搏联合麝香保心丸治疗急性心肌梗死伴左心衰疗效观察[J].现代中西医结合杂志,2017,26(16):1807-1809.[10]彭雪,王文娟,赵莉,等.血清PlGF和sFlt-1评估慢性心力衰竭患者心功能分级的临床价值研究[J].中国循证心血管医学杂志,2020,12(12):1465-1469.[11]陈鑫,韩钟霖,石秀,等.主动脉内球囊反搏辅助介入治疗急性心肌梗死伴心力衰竭患者疗效评价[J].疑难病杂志,2016,15(10):991-993.[12]高志伟,黄英姿,孙青松,等.主动脉内球囊反搏对急性心肌梗死经皮冠状动脉介入治疗后30d内死亡率的影响[J].中华全科医师杂志,2017,16(7):527-531.[13]张文,卢宏彪,胡大清.高龄急性心肌梗死患者在膜肺氧合联合主动脉内球囊反搏下介入治疗一例[J].中华老年心脑血管病杂志,2015,17(5):540-541.[14]Lin LY,Liao CW,Wang CH,et al.Effects of Additional Intra-aortic Bal-loon Counter-Pulsation Therapy to Cardio-genic Shock Patients Supported by Extracorporeal Membranous Oxygenation[J].Scientific Reports,2016,6(58):23838.[15]王霁翔,高静,任珉,等.早期保护性肺通气和主动脉内球囊反搏联合急诊经皮冠状动脉介入治疗急性心肌梗死合并心源性休克的疗效[J].中华老年医学杂志,2017,36(7):724-729.[16]毛亚妮,樊川民.主动脉球囊反搏联合参附注射液对急性心肌梗死合并泵衰竭行PCI治疗患者的疗效观察[J].中国循证心血管医学杂志,2016,8(7):850-852.[17]刘玉杰.主动脉内球囊反搏联合PCI改善急性心肌梗死合并心源性休克患者预后的研究[J].海南医学院学报,2016,22(1):37-40.[18]韩晓霞,李秀兰,刘秀红,等.急性心肌梗死伴心泵衰竭患者行主动脉内球囊反搏术围术期血液动力学变化[J].临床和实验医学杂志,2016,15(8):760-762.[19]陈少敏,马贵洲,陈平,等.主动脉内球囊反搏对直接经皮冠状动脉介入治疗后无复流的急性广泛前壁心肌梗死患者心功能的影响[J].岭南心血管病杂志,2016,22(4):415-418.

相似文献/References:

[1]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
　ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(13):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[2]李 铎.β受体阻滞剂预处理对AMI介入治疗患者心室重构、 自主神经功能恢复的影响研究[J].医学信息,2018,31(09):91.[doi:10.3969/j.issn.1006-1959.2018.09.027]
　LI Duo.Effect of β-blocker Preconditioning on Ventricular Remodeling and Autonomic Nerve Function Recovery in Patients Undergoing AMI Intervention[J].Medical Information,2018,31(13):91.[doi:10.3969/j.issn.1006-1959.2018.09.027]
[3]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
　TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Medical Information,2022,35(13):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[4]赵洪伟,刘福全,岳振东,等.临床路径与提问式教学法在介入治疗专业中的应用和探索[J].医学信息,2018,31(14):5.[doi:10.3969/j.issn.1006-1959.2018.14.003]
　ZHAO Hong-wei,LIU Fu-quan,YUE Zhen-dong,et al.Application and Exploration of Clinical Pathway and Question-based Teaching Method in Interventional Therapy[J].Medical Information,2018,31(13):5.[doi:10.3969/j.issn.1006-1959.2018.14.003]
[5]何明峰,高 飞,马兴洲,等.双入路和逆向开通治疗左侧锁骨下动脉慢性闭塞的临床研究[J].医学信息,2018,31(15):178.[doi:10.3969/j.issn.1006-1959.2018.15.060]
　HE Ming-feng,GAO Fei,MA Xing-zhou,et al.Clinical Study of Double Approach and Reverse Opening for the Treatment of Chronic Occlusion of the Left Subclavian Artery[J].Medical Information,2018,31(13):178.[doi:10.3969/j.issn.1006-1959.2018.15.060]
[6]吴森林,高 斌.中性粒细胞/淋巴细胞比值与介入治疗中晚期非小细胞肺癌患者预后的相关性[J].医学信息,2019,32(03):82.[doi:10.3969/j.issn.1006-1959.2019.03.025]
　WU Sen-lin,GAO Bin.Correlation between Neutrophil/Lymphocyte Ratio and Prognosis in Patients with Advanced Non-small Cell Lung Cancer[J].Medical Information,2019,32(13):82.[doi:10.3969/j.issn.1006-1959.2019.03.025]
[7]何进舟,陈德彬,郭厚玲.介入治疗对冠心病合并左心功能不全患者的心功能 及生活质量的影响[J].医学信息,2019,32(18):78.[doi:10.3969/j.issn.1006-1959.2019.18.024]
　HE Jin-zhou,CHEN De-bin,GUO Hou-ling.Effect of Interventional Therapy on Cardiac Function and Quality of Life in Patients with Coronary Heart Disease Complicated with Left Ventricular Dysfunction[J].Medical Information,2019,32(13):78.[doi:10.3969/j.issn.1006-1959.2019.18.024]
[8]王永智.经皮冠状动脉介入治疗冠心病研究进展[J].医学信息,2019,32(16):41.[doi:10.3969/j.issn.1006-1959.2019.16.013]
　WANG Yong-zhi.Progress in Percutaneous Coronary Intervention for Coronary Heart Disease[J].Medical Information,2019,32(13):41.[doi:10.3969/j.issn.1006-1959.2019.16.013]
[9]邓 伟.血必净注射液预防STEMI患者直接介入治疗后冠脉无复流的效果[J].医学信息,2020,33(17):163.[doi:10.3969/j.issn.1006-1959.2020.17.049]
　DENG Wei.Effect of Xuebijing Injection in Preventing Coronary Artery No-reflow After Direct Interventional Therapy in STEMI Patients[J].Medical Information,2020,33(13):163.[doi:10.3969/j.issn.1006-1959.2020.17.049]
[10]魏艳慧.自我管理教育在介入治疗血栓闭塞性脉管炎中的应用效果[J].医学信息,2022,35(22):187.[doi:10.3969/j.issn.1006-1959.2022.22.046]
　WEI Yan-hui.Application Effect of Self-management Education in Interventional Treatment of Thromboangiitis Obliterans[J].Medical Information,2022,35(13):187.[doi:10.3969/j.issn.1006-1959.2022.22.046]

更新日期/Last Update: 1900-01-01